By Joel Lord As far back as 2006 no fewer than 4 major pharmaceutical companies had applied for vaccine patents to combat a novel strain of H1N1 virus: GlaxoSmythKline, Novartis, Baxter International & Medimmune: GlaxoSmithKline Patent WO2006100109 A1 / March 21st, 2006 http://www.theoneclickgroup.co.uk/documents/vaccines/WO2006100109A1.pdf Novartis Patent US 20090047353 / November 6th, 2006 http://www.freshpatents.com/-dt20090219ptan20090047353.php?type=description Baxter Patent US […]